intrathecal rituximab

DRUG3 trials

Sponsors

International Extranodal Lymphoma Study Group (IELSG), M.D. Anderson Cancer Center, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Conditions

Child, OnlyLeukemiaLymphoid MalignanciesLymphoma, B CellLymphoma, Non-HodgkinMetastatic Malignant Neoplasm to the Leptomeninges

Phase 1

A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis

WithdrawnNCT00210340

International Extranodal Lymphoma Study Group (IELSG)Lymphoma, B Cell

Updated: 2015-03-30

Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System

TerminatedNCT01596127

M.D. Anderson Cancer CenterLeukemia, Lymphoid Malignancies, Metastatic Malignant Neoplasm to the Leptomeninges

Start: 2013-01-24End: 2017-03-23Updated: 2018-05-24

Unknown Phase

Safety and Efficacy of Intrathecal Rituximab in 16 Children of Stage Ⅲ、ⅣNon-Hodgkin Lymphoma

CompletedNCT06190457

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityChild, Only, Lymphoma, Non-Hodgkin

Start: 2015-09-30End: 2022-08-30Updated: 2024-01-05